MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pntd.0006376

Медицинская библиотека · PLoS neglected tropical diseases · 2018

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Islam Kamrul, Hossain Motaher, Kelly Meagan, Mayo Smith Leslie M, Charles Richelle C, Bhuiyan Taufiqur Rahman, Kováč Pavol, Xu Peng, LaRocque Regina C, Calderwood Stephen B, Simon Jakub K, Chen Wilbur H, Haney Douglas, Lock Michael, Lyon Caroline E, Kirkpatrick Beth D, Cohen Mitchell, Levine Myron M, Gurwith Marc, Harris Jason B, Qadri Firdausi, Ryan Edward T

Клиническое исследование III фазыСтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Cholera is an acute voluminous dehydrating diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and occasionally O139. A growing body of evidence indicates that immune responses targeting the O-specific polysaccharide (OSP) of V. cholerae are involved in mediating protection against cholera. We therefore assessed whether antibody responses against OSP occur after vaccination with live attenuated oral cholera vaccine CVD 103-HgR, and whether such responses correlate with protection against cholera.

METHODOLOGY: We assessed adult North American volunteers (n = 46) who were vaccinated with 5 × 108 colony-forming units (CFU) of oral cholera vaccine CVD 103-HgR and then orally challenged with approximately 1 × 105 CFU of wild-type V. cholerae O1 El Tor Inaba strain N16961, either 10 or 90 days post-vaccination.

PRINCIPAL FINDINGS: Vaccination was associated with induction of significant serum IgM and IgA anti-OSP and vibriocidal antibody responses within 10 days of vaccination. There was significant correlation between anti-OSP and vibriocidal antibody responses. IgM and IgA anti-OSP responses on day 10 following vaccination were associated with lower post-challenge stool volume (r = -0.44, P = 0.002; r = -0.36, P = 0.01; respectively), and none of 27 vaccinees who developed a ≥1.5 fold increase in any antibody isotype targeting OSP on day 10 following vaccination compared to baseline developed moderate or severe cholera following experimental challenge, while 5 of 19 who did not develop such anti-OSP responses did (P = 0.01).

CONCLUSION

Oral vaccination with live attenuated cholera vaccine CVD 103-HgR induces antibodies that target V. cholerae OSP, and these anti-OSP responses correlate with protection against diarrhea following experimental challenge with V. cholerae O1.

TRIAL REGISTRATION: ClinicalTrials.gov NCT01895855.

Для цитирования: Islam Kamrul, Hossain Motaher, Kelly Meagan, Mayo Smith Leslie M, Charles Richelle C, Bhuiyan Taufiqur Rahman, Kováč Pavol, Xu Peng, LaRocque Regina C, Calderwood Stephen B, Simon Jakub K, Chen Wilbur H, Haney Douglas, Lock Michael, Lyon Caroline E, Kirkpatrick Beth D, Cohen Mitchell, Levine Myron M, Gurwith Marc, Harris Jason B, Qadri Firdausi, Ryan Edward T. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.. PLoS neglected tropical diseases. 2018. DOI: 10.1371/journal.pntd.0006376.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.